Arch Therapeutics, Inc.
ARTHDelisted- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001537561
Arch Therapeutics, Inc. was delisted in 2022; its insiders filed their last Form 4 on Sep 8, 2023; 1 institution reported holding it in 13F filings for Q3 2022, worth $0 in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Arch Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Arch Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Abrams Michael S | CHIEF FINANCIAL OFFICER | 10,292 | Sep 8, 2023 | 0 |
| Norchi Terrence W | PRESIDENT AND CHIEF EXECUTIVE | 6,862 | Sep 8, 2023 | 0 |
| Hicks Laurence | Director | 10,292Indirect | Sep 8, 2023 | 0 |
| Dhillon Punit | Director | – | Nov 10, 2022 | 0 |
| Yrigoyen Dan | VICE PRESIDENT, SALES | 150,000 | Nov 10, 2022 | 0 |
| Fish Guy L. | Director | – | Nov 10, 2022 | 0 |
| Sulat James R | Director | – | Oct 1, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2023 (view filing)5:47 PM ET | Aug 31 | 8 daysLate | Abrams Michael SCHIEF FINANCIAL OFFICER | PPurchase | +10.3K | $0.275 | +$2.83K | New position10.3K after | Duplicate filing |
| Sep 8, 2023 (view filing)5:47 PM ET | Aug 31 | 8 daysLate | Norchi Terrence WPRESIDENT AND CHIEF EXECUTIVE | PPurchase | +6.86K | $0.275 | +$1.89K | New position6.86K after | |
| Sep 8, 2023 (view filing)5:47 PM ET | Aug 31 | 8 daysLate | Hicks LaurenceDirector | PPurchase | +10.3K | $0.275 | +$2.83K | New position10.3K after |